Spots Global Cancer Trial Database for cancer cachexia
Every month we try and update this database with for cancer cachexia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss | NCT00094562 | Cancer Cancer Cachexia Chronic Obstruc... Chronic Heart F... Rheumatoid Arth... | Fish oil supple... | 18 Years - 90 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Study of Branched-chain Amino Acids in Cancer Cachexia | NCT03253029 | Cancer Cachexia | Pure Encapsulat... control group (... | 18 Years - | Western Regional Medical Center | |
| Florida Pancreas Collaborative Next Generation Biobank | NCT03851133 | Pancreatic Canc... Cancer Cachexia | Blood Sample Co... Tumor Sample co... Data Collection | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma | NCT05376592 | Pancreas Adenoc... Cachexia | 18 Years - | Wake Forest University Health Sciences | ||
| Vitamin D for Muscle Metabolic Function in Cancer Cachexia | NCT03144128 | Cancer Cachexia Vitamin D Defic... | Vitamin D Placebo | 45 Years - 75 Years | University of Kentucky | |
| Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia | NCT01614990 | Cancer Cachexia | Macimorelin Placebo | - | Garcia, Jose M., MD, PhD | |
| The Role of Ghrelin in Cancer Cachexia | NCT01505764 | Cancer Cachexia | Anamorelin HCl Placebo | 18 Years - | VA Office of Research and Development | |
| Multimodal Treatment Strategy for Cancer Cachexia | NCT00625742 | Advanced Cancer Cachexia | Graded Resistan... Aerobic Exercis... Melatonin Juven Atenolol Ibuprofen | 18 Years - | M.D. Anderson Cancer Center | |
| Effects of WB-EMS and Specific Dietary Supplements on Cancer Patients | NCT03151291 | Cancer Cancer Cachexia Weight Loss Muscle Loss Muscle Weakness | β-hydroxy-β-met... L-carnitine (LC... Eicosapentaenoi... Whole-Body Elec... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Patient Recorded Indexing Measurements | NCT05899205 | Cachexia Cancer Weight, Body | 18 Years - 80 Years | Academisch Ziekenhuis Maastricht | ||
| Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant Diseases | NCT04067167 | Cancer Cancer Cachexia Inflammation Muscular Atroph... | WB-EMS (Sham-in... WB-EMS Free WB-EMS Flexi band resi... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss | NCT00094562 | Cancer Cancer Cachexia Chronic Obstruc... Chronic Heart F... Rheumatoid Arth... | Fish oil supple... | 18 Years - 90 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Effect of Gene Polymorphisms on the Pathogenesis of Cancer Cachexia | NCT04131478 | Cancer Cachexia | Pharmacogenetic... | 18 Years - 80 Years | Cairo University | |
| Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant Diseases | NCT04067167 | Cancer Cancer Cachexia Inflammation Muscular Atroph... | WB-EMS (Sham-in... WB-EMS Free WB-EMS Flexi band resi... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss | NCT00219817 | Cancer Cachexia | RC-1291 HCl | 18 Years - | Helsinn Therapeutics (U.S.), Inc | |
| Cancer Anorexia and the Central Nervous System | NCT01564693 | Cancer Cachexia | 18 Years - 85 Years | University of Roma La Sapienza | ||
| Parenteral Nutrition Support for Patients With Pancreatic Cancer | NCT00919659 | Cancer Cachexia Pancreatic Canc... | parenteral nutr... | 18 Years - | CONKO-Studiengruppe | |
| Medical Imaging of Cachexia | NCT04127981 | Cancer Cachexia | 18F-FDG PET + D... | 18 Years - | Olivia Newton-John Cancer Research Institute | |
| The Effects of n-3 LCPUFAs in Patients With Colorectal Cancer | NCT04699760 | Cancer Cachexia Side Effects Quality of Life | Fish Oil Placebo | 18 Years - 90 Years | University of Copenhagen | |
| The Role of Ghrelin in Cancer Cachexia | NCT01505764 | Cancer Cachexia | Anamorelin HCl Placebo | 18 Years - | VA Office of Research and Development | |
| Physical Training for Elderly Cancer Patients With Cachexia | NCT05915325 | Geriatric Asses... Cancer Cancer Cachexia | Physical traini... | 65 Years - | National Cheng-Kung University Hospital | |
| Insulin Treatment in Cancer Cachexia | NCT00329615 | Cancer Cachexia | Insulatard, fle... | 25 Years - 85 Years | Göteborg University | |
| L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN) | NCT01330823 | Pancreatic Carc... | L-Carnitine Placebo | - | University Medicine Greifswald | |
| A First in Human Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics Effects of OC514 | NCT05264038 | Cancer Cachexia | OC514 (Low dose... OC514 (Mid dose... OC514 (High dos... Placebo | 18 Years - 65 Years | Oncocross Co. Ltd. | |
| Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases. | NCT02072057 | Cancer Cachexia | Ruxolitinib | 18 Years - | Kantonsspital Aarau | |
| Effects of WB-EMS and Dietetic Treatment on Cancer Patients | NCT02293239 | Cancer Cancer Cachexia Weight Loss Muscle Loss Muscle Weakness | Whole-Body Elec... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Study of Branched-chain Amino Acids in Cancer Cachexia | NCT03253029 | Cancer Cachexia | Pure Encapsulat... control group (... | 18 Years - | Western Regional Medical Center | |
| Novel Form of Nutritional Supplementation in Cancer Patients | NCT03561610 | Cancer Malnutrition Cachexia | sip feed gumdrops | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Vitamin D for Muscle Metabolic Function in Cancer Cachexia | NCT03144128 | Cancer Cachexia Vitamin D Defic... | Vitamin D Placebo | 45 Years - 75 Years | University of Kentucky | |
| Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia | NCT01614990 | Cancer Cachexia | Macimorelin Placebo | - | Garcia, Jose M., MD, PhD | |
| Muscle Stimulation for Physical Function During Stem Cell Transplant | NCT04364256 | Autologous Hema... | RS-4i Plus Sequ... | 18 Years - | VA Office of Research and Development | |
| Multimodal Treatment Strategy for Cancer Cachexia | NCT00625742 | Advanced Cancer Cachexia | Graded Resistan... Aerobic Exercis... Melatonin Juven Atenolol Ibuprofen | 18 Years - | M.D. Anderson Cancer Center | |
| Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia | NCT00378131 | Cancer Cachexia | RC-1291 placebo | 18 Years - | Helsinn Therapeutics (U.S.), Inc | |
| Feasibility and Effect of Resistance Training and Protein Supplementation in Patients With Advanced Gastroesophageal Cancer | NCT05650827 | Gastro-esophage... | Resistance trai... Protein supplem... | 18 Years - | Rigshospitalet, Denmark | |
| Effects of WB-EMS and Dietetic Treatment on Cancer Patients | NCT02293239 | Cancer Cancer Cachexia Weight Loss Muscle Loss Muscle Weakness | Whole-Body Elec... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia | NCT00815685 | Cancer Cachexia | Eicosapentaenoi... | 25 Years - 80 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Cancer-associated Cachexia in Patients With Incurable Gastroesophageal Cancer | NCT06137508 | Gastro-Esophage... | 18 Years - | Rigshospitalet, Denmark | ||
| Enteral Omega 3 During Radiotherapy to Improve the Quality of Life and Functionality of Head and Neck Cancer Patients | NCT03720158 | Head and Neck S... Quality of Life Radiotherapy; C... | Omega 3 Group Placebo or Cont... | 18 Years - 85 Years | Coordinación de Investigación en Salud, Mexico | |
| A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia | NCT00815685 | Cancer Cachexia | Eicosapentaenoi... | 25 Years - 80 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases. | NCT02072057 | Cancer Cachexia | Ruxolitinib | 18 Years - | Kantonsspital Aarau | |
| Chemotherapy-related Toxicity, Nutritional Status and Quality of Life | NCT02848807 | Toxicity Due to... Cancer Cachexia Metastatic Colo... Quality of Life Dietary Modific... | NUTRIDRINK Comp... | 18 Years - | University Clinical Centre, Gdansk | |
| Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training | NCT00196885 | Gastrointestina... Bronchial Carci... Hodgkin Disease Non-Hodgkin Lym... Weight Loss | N-acetylcystein... | 20 Years - 80 Years | German Cancer Research Center | |
| Predicting Lung Cancer-Associated Cachexia With PET Imaging | NCT05912465 | Cachexia Lung Neoplasm | Stress Reductio... | 18 Years - | Medical University of Vienna | |
| Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training | NCT00196885 | Gastrointestina... Bronchial Carci... Hodgkin Disease Non-Hodgkin Lym... Weight Loss | N-acetylcystein... | 20 Years - 80 Years | German Cancer Research Center | |
| Enteral Omega 3 During Radiotherapy to Improve the Quality of Life and Functionality of Head and Neck Cancer Patients | NCT03720158 | Head and Neck S... Quality of Life Radiotherapy; C... | Omega 3 Group Placebo or Cont... | 18 Years - 85 Years | Coordinación de Investigación en Salud, Mexico | |
| A Clinical Study With MT-102 in Subjects With Cancer Cachexia | NCT01238107 | Cancer Cachexia | MT-102 | 25 Years - 80 Years | Akamis Bio | |
| Nutrition Education and Quality of Life in Cancer Cachexia | NCT05262192 | Cancer Cachexia | nutrition educa... | 50 Years - 80 Years | T.C. ORDU ÜNİVERSİTESİ | |
| A First in Human Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics Effects of OC514 | NCT05264038 | Cancer Cachexia | OC514 (Low dose... OC514 (Mid dose... OC514 (High dos... Placebo | 18 Years - 65 Years | Oncocross Co. Ltd. | |
| Nutrition Education and Quality of Life in Cancer Cachexia | NCT05262192 | Cancer Cachexia | nutrition educa... | 50 Years - 80 Years | T.C. ORDU ÜNİVERSİTESİ | |
| Protein-rich Nutritional Therapy Combined With Time-efficient Exercise in Cancer Therapy | NCT04065815 | Cancer Cancer Cachexia Inflammation | Resistance Trai... WB-EMS High-intensity ... Combined HIIT a... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| The Safety and Effect Study of Acupuncture for Anorexia in Patients With Gastrointestinal Tract and Lung Cancers | NCT02619266 | Anorexia Cancer Cachexia | Acupuncture Sham Acupunctur... Megestrol Aceta... Placebo(Megestr... | 18 Years - | Xinqiao Hospital of Chongqing | |
| Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma | NCT05376592 | Pancreas Adenoc... Cachexia | 18 Years - | Wake Forest University Health Sciences | ||
| Medical Imaging of Cachexia | NCT04127981 | Cancer Cachexia | 18F-FDG PET + D... | 18 Years - | Olivia Newton-John Cancer Research Institute | |
| A First in Human Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics Effects of OC514 | NCT05264038 | Cancer Cachexia | OC514 (Low dose... OC514 (Mid dose... OC514 (High dos... Placebo | 18 Years - 65 Years | Oncocross Co. Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
